Cero Therapeutics Holdings CERO
OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) Accumulated Expenses (2023 - 2026)

Updated

Cero Therapeutics Holdings (CERO) recorded Accumulated Expenses of $485,009 in Q2 2026, up 32.9% from $365,060 a year earlier but down 3.2% from the prior quarter.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2025, Cero Therapeutics Holdings reported Accumulated Expenses of $363,811, down 81.0% from FY2024.

  • Across earlier years, Accumulated Expenses came in at $1.91 million in FY2024 and $144,633 in FY2023.
  • Quarterly Accumulated Expenses has ranged from $144,633 in Q4 2023 to $1.91 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Accumulated Expenses rose in three of the last six quarters, with an average decline of 21.7%.
  • Per Business Quant, the preceding three quarters came in at $500,788 (Q1 2026), $363,811 (Q4 2025) and $340,691 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 485,009.00
Mar 31, 2026 500,788.00
Dec 31, 2025 363,811.00
Sep 30, 2025 340,691.00
Jun 30, 2025 365,060.00
Mar 31, 2025 469,659.00
Dec 31, 2024 1.91 Mn
Sep 30, 2024 1.69 Mn
Jun 30, 2024 1.16 Mn
Mar 31, 2024 294,343.00
Dec 31, 2023 144,633.00
API Access

Cero Therapeutics Holdings, Inc. Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CERO&period=max&api_key=YOUR_API_KEY